Does Bergamot Blood Pressure Randomized Trial work?

Updated August 2026

Quick Answer

Bergamot Blood Pressure Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background Subsyndromal generalized anxiety is highly prevalent and associated with impaired well-being, elevated stress, and functional limitations, yet affected individuals often do not meet criteria for guideline-based treatment.

Key Takeaways

  • 01Background Subsyndromal generalized anxiety is highly prevalent and associated with impaired well-being, elevated stress, and functional limitations, yet affected individuals often do not meet criteria for guideline-based treatment. [Ngandeu Schepanski S (2026)]
  • 02Discussion This study is expected to provide evidence on the efficacy of essential oil-enhanced digital hypnosis for subsyndromal anxiety and will examine whether repeated pairing of hypnosis and olfactory stimulation induces conditioned relaxation responses. [Ngandeu Schepanski S (2026)]
  • 03If effective, this multimodal, low-intensity intervention could represent a scalable preventive approach for individuals with increased anxiety who are not receiving formal treatment and have been medically diagnosed. [Ngandeu Schepanski S (2026)]
  • 04Scalable, low-threshold digital interventions that target psychophysiological regulation may help address this gap. [Ngandeu Schepanski S (2026)]
The current Migaku evidence database contains 2 reusable source documents for Bergamot Blood Pressure Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Background Subsyndromal generalized anxiety is highly prevalent and associated with impaired well-being, elevated stress, and functional limitations, yet affected individuals often do not meet criteria for guideline-based treatment. [Ngandeu Schepanski S (2026); evidence level 2] - Discussion This study is expected to provide evidence on the efficacy of essential oil-enhanced digital hypnosis for subsyndromal anxiety and will examine whether repeated pairing of hypnosis and olfactory stimulation induces conditioned relaxation responses. [Ngandeu Schepanski S (2026); evidence level 2] - If effective, this multimodal, low-intensity intervention could represent a scalable preventive approach for individuals with increased anxiety who are not receiving formal treatment and have been medically diagnosed. [Ngandeu Schepanski S (2026); evidence level 2] - Scalable, low-threshold digital interventions that target psychophysiological regulation may help address this gap. [Ngandeu Schepanski S (2026); evidence level 2] - Epidemiological studies indicate that CRS affects a substantial proportion of patients, with an estimated prevalence of up to 0.4% in the general population and 2–3% in individuals with diabetes and heart failure, and is associated with increased morbidity and mortality [,]. [Carollo Caterina (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Essential Oil-enhanced digital hypnotherapy for subclinical generalized anxiety: a study protocol for a randomized controlled trial.
  2. Nature’s Bioactives in Cardiorenal Syndrome: Polyphenols at the Crossroads—Preclinical Insights into Redox, Inflammation, and Mitochondrial Protection